# Osteoarticular infections in children in Qatar: A retrospective study

**Authors:** Mohamed Elkalaf, Shabina Khan, Maisaa Elzain, Eiman Hamid, Saira Shehzad, Khalid Al-Kharraz, Tawa Olukade, Mohammed Alkuwari, Mohammed Al Amri, Ashraf Soliman, Sahnoun Ahmed Khalil

PMC · DOI: 10.5339/qmj.2025.69 · Qatar Medical Journal · 2025-08-20

## TL;DR

This study examines osteoarticular infections in children in Qatar, focusing on their clinical features, common pathogens, and treatment outcomes.

## Contribution

A retrospective analysis of pediatric osteoarticular infections in Qatar, highlighting clinical and microbiological trends.

## Key findings

- Staphylococcus aureus was the most common pathogen, with nearly half being methicillin-resistant.
- Concurrent infections were associated with longer hospital stays and higher complication rates.
- Magnetic resonance imaging showed abnormalities in all patients, while ultrasound showed abnormalities in 75%.

## Abstract

Osteoarticular infections (OAIs) in Qatar’s pediatric population represent a significant source of morbidity, highlighting the need for a comprehensive evaluation of their clinical, microbiological, and treatment characteristics. Understanding the presentation and management of these infections is essential for optimizing patient outcomes and guiding future therapeutic approaches.

Retrospective cohort study of 62 hospitalized children with OAIs treated at Hamad Medical Corporation from 2016 to 2018.

Over 2 years, 62 patients were diagnosed and treated for OAIs. Osteomyelitis emerged as the most prevalent infection type, comprising 48.4% of cases, followed by septic arthritis at 20.9% and concurrent infections at 17.7%. The cohort demonstrated a male predominance of 66.1%. The common clinical manifestations included fever (77.4%), functional limitations (82.3%), and pain (88.7%). Staphylococcus aureus was the most frequently isolated pathogen, present in 24.1% (15/62) of cases, with approximately 50% of these being methicillin-resistant Staphylococcus aureus. Among the radiological studies conducted, 75% revealed abnormal ultrasound findings, while all patients exhibited abnormal magnetic resonance imaging results (n = 53). The antibiotic regimen most frequently prescribed was clindamycin (79%), followed by the cephalosporin ceftriaxone (67.7%). The group with concurrent infections showed the longest duration of both parenteral and oral antibiotic therapy, the highest complication rates, and the longest median hospital stay of 21 days.

OAIs present substantial clinical challenges, marked by complex presentations and diagnostic difficulties. Staphylococcus aureus remains the predominant pathogen, with methicillin-resistant Staphylococcus aureus accounting for nearly half of the cases. Concurrent infections are linked with more severe complications and prolonged hospitalizations, though they also exhibit the highest rates of positive microbiological results.

## Linked entities

- **Chemicals:** clindamycin (PubChem CID 446598), ceftriaxone (PubChem CID 5479530)
- **Diseases:** osteomyelitis (MONDO:0005246), septic arthritis (MONDO:0004471)

## Full-text entities

- **Genes:** CRP (C-reactive protein) [NCBI Gene 1401] {aka PTX1}, UROD (uroporphyrinogen decarboxylase) [NCBI Gene 7389] {aka PCT, UPD}
- **Diseases:** bone and joint infections (MESH:D001847), DVT (MESH:D020246), joint stiffness (MESH:C535724), rheumatologic (MESH:D012216), Infection (MESH:D007239), Multifocal Osteomyelitis (MESH:C535456), bacteremia (MESH:D016470), immunodeficiency (MESH:D007153), death (MESH:D003643), angular deformities (MESH:D065170), idiopathic arthritis (MESH:D001168), MRSA (MESH:D013203), sepsis (MESH:D018805), infectious disease (MESH:D003141), invasive diseases (MESH:D009361), septic shock (MESH:D012772), limitation of function (MESH:D045745), SA (MESH:D001170), OM (MESH:D010019), mediastinitis (MESH:D008480), bacterial (MESH:D001424), bursitis (MESH:D002062), multiorgan failure (MESH:D051437), LOS (MESH:D007870), avascular necrosis (MESH:D010020), pain (MESH:D010146), mastoiditis (MESH:D008417), bone tumor (MESH:D001859), sinusitis (MESH:D012852), growth arrest (MESH:D006130), trauma (MESH:D014947), abscess (MESH:D000038), inflammation (MESH:D007249), fever (MESH:D005334), OAIs (MESH:D014394), microbial infection (MESH:D015163)
- **Chemicals:** Rifampicin (MESH:D012293), cephalosporin (MESH:D002511), Piperacillin-Tazobactam (MESH:D000077725), Ceftriaxone (MESH:D002443), Cefuroxime (MESH:D002444), cephalexin (MESH:D002506), pneumococcal conjugate (-), Flucloxacillin (MESH:D005436), Cefazolin (MESH:D002437), Amoxicillin-Clavulanate (MESH:D019980), methicillin (MESH:D008712), Gentamicin (MESH:D005839), Vancomycin (MESH:D014640), Cloxacillin (MESH:D003023), Clindamycin (MESH:D002981)
- **Species:** Homo sapiens (human, species) [taxon 9606], Staphylococcus aureus (species) [taxon 1280], Pseudomonas aeruginosa (species) [taxon 287], Streptococcus pyogenes (species) [taxon 1314], Kingella kingae (species) [taxon 504], Streptococcus pneumoniae (species) [taxon 1313]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12894351/full.md

## References

35 references — full list in the complete paper: https://tomesphere.com/paper/PMC12894351/full.md

---
Source: https://tomesphere.com/paper/PMC12894351